Krystal Biotech buy Bank of America Co.
Start price
22.01.26
/
50%
€246.10
Target price
22.01.27
€272.02
Performance (%)
-8.49%
Price
19:08
€225.20
Summary
This prediction is currently active. With a performance of -8.49%, the BUY prediction for Krystal Biotech by Bank_of_America_Co_ is down slightly. This prediction currently runs until 22.01.27. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Krystal Biotech | 0.615% | 0.615% |
| iShares Core DAX® | 4,24 % | 2,86 % |
| iShares Nasdaq 100 | 4,89 % | 2,81 % |
| iShares Nikkei 225® | 9,40 % | 7,83 % |
| iShares S&P 500 | 3,53 % | 1,95 % |
Comments by Bank_of_America_Co_ for this prediction
In the thread Krystal Biotech diskutieren
Krystal Biotech (NASDAQ:KRYS) had its price target raised by analysts at Bank of America Corporation from $288.00 to $318.00. They now have a "buy" rating on the stock.
Ratings data for KRYS provided by MarketBeat